One of the biggest questions in designing and interpreting results from immunoassays is the quality of T-cell response; this is an especially intriguing issue now that newer research has suggested that T-cell and B-cell responses might not be interconnected in the popularly-assumed manner. Though very new, elispot assays are very useful in answering these questions and also for eliminating background variability. At our upcoming Bioanalytical Method Development & Bioassays event, Medimmune will be sharing results on this topic with a case study.For more information on this session and the rest of the event, download the agenda. As a reader of this blog, when you register to join us this October 1-3 in Berkley, California and mention code XP1768BLOG, you'll save 15% off the standard rate!
Featured Session: Elispot Assays to Pinpoint the Quality of T-cell ResponseFeatured Speakers: Lokesh Agrawal, PhD, Project Director, R&D, Translational Medicine, MEDIMMUNE
About the session: Novel cell-based assay designs can allow you to clearly document the decrease in cell signals in neutralizing serum without having to rely on a reporter RSV virus. These techniques will depict GFP expression with the clarity you need to grade vaccine efficacy. Elispot assay techniques, while new, are particularly useful in eliminating background variability and pinpointing the quality of T-cell response.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment